Just five analysts cover the stock, according to FactSet data, but they have an average price target of $10.40, implying a ...

The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...

Both biotechs are a bit risky, but could benefit from clinical progress this year -- and the upside would be huge. CRISPR has ...

So far this month, investors have poured $2.6 billion into follow-on rounds for public biotechs — the most ever for the ...

Depending who you ask, AI-powered coding is either giving software developers an unprecedented productivity boost or churning ...

The companies Kymera Therapeutics, Immunovant, and Dyne Therapeutics bagged the biggest biotech funding rounds overall in ...

Biotech investors spent years waiting for the sector to recover from its brutal 2021 peak. That patience is finally paying ...

Venture capitalists point to a surge in M&A and a glint of revival in the IPO arena as signs of better days ahead.

The opening session sets the context and intent for the Inaugural Summit: USA-Saudi Biotech Alliance, outlining the strategic ...

Attend or sponsor our commercial real estate event in San Diego: Southern California Life Sciences & Biotech Summit.

Sunil Chari, Co-founder and Managing Director of Rossari Biotech, said the company plans to exit its loss-making B2C and consumer cleaning businesses. Management added that steps toward this exit will ...